Insiders Aurinia Pharmaceuticals Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-09 pm EDT			5-day change	1st Jan Change
5.52 ^USD	-1.95%		+1.66%	-38.60%

Jul. 01	Aurinia Pharmaceuticals Inc.(NasdaqGM:AUPH) added to Russell Small Cap Comp Value Index	CI
Jul. 01	Aurinia Pharmaceuticals Inc.(NasdaqGM:AUPH) added to Russell 2500 Value Index	CI

Aurinia Pharmaceuticals Insider Sold Shares Worth $711,094, According to a Recent SEC Filing	Mar. 07	MT
Aurinia Pharmaceuticals Insider Sold Shares Worth $323,372, According to a Recent SEC Filing	Mar. 07	MT
Aurinia Pharmaceuticals Appoints Robert T. Foster to its Board	23-09-21	CI
Aurinia Pharmaceuticals Inc. Announces Board Changes	23-08-21	CI
Sector Update: Health Care Stocks Advance Premarket Friday	23-06-30	MT
Aurinia Pharmaceuticals Inc. Announces Board Resignations	23-06-29	CI
Institutional Shareholder Services Inc Recommends Aurinia Shareholders Vote Against the Company’s Named Executive Officers’ Compensation	23-05-03	CI
Insider Sell: Aurinia Pharmaceuticals	23-03-06	MT
Insider Sell: Aurinia Pharmaceuticals	23-03-06	MT
Insider Sell: Aurinia Pharmaceuticals	23-03-06	MT
Insider Buy: Aurinia Pharmaceuticals	22-11-09	MT
Aurinia Pharmaceuticals Inc. Announces Management Departures	22-10-21	CI
Aurinia Pharmaceuticals Names New Chief Commercial Officer As Colao Leaving; Shares Sink	22-07-15	MT
Aurinia Pharmaceuticals' Chief Commercial Officer Max Colao to Leave on July 22	22-07-15	MT
Aurinia Pharmaceuticals Appoints Scott Habig Chief Commercial Officer	22-07-14	MT
Aurinia Announces the Addition of Three Seasoned Executive Leaders to Advance Company Strategy and Performance	22-07-14	CI
Insider Sell: Aurinia Pharmaceuticals	22-03-04	MT
Insider Sell: Aurinia Pharmaceuticals	21-10-26	MT
Insider Sell: Aurinia Pharmaceuticals	21-09-22	MT
Insider Sell: Aurinia Pharmaceuticals	21-09-22	MT

No results for this search